import{_ as e,o as i,c as t,O as a}from"./chunks/framework.9482e208.js";const f=JSON.parse('{"title":"§ 54.1-3442.1 Definitions.","description":"","frontmatter":{},"headers":[],"relativePath":"vacode/54.1-3442.1.md","filePath":"vacode/54.1-3442.1.md"}'),n={name:"vacode/54.1-3442.1.md"},o=a('<h1 id="§-54-1-3442-1-definitions" tabindex="-1">§ 54.1-3442.1 Definitions. <a class="header-anchor" href="#§-54-1-3442-1-definitions" aria-label="Permalink to &quot;§ 54.1-3442.1 Definitions.&quot;">​</a></h1><p>As used in this article, unless the context requires a different meaning:</p><p>&quot;Investigational drug, biological product, or device&quot; means a drug, biological product, or device that has successfully completed Phase I of a clinical trial but has not been approved for general use by the U.S. Food and Drug Administration and remains under investigation in a clinical trial.</p><p>&quot;Terminal condition&quot; means a condition caused by injury, disease, or illness from which, to a reasonable degree of medical probability, a patient cannot recover and (i) the patient&#39;s death is imminent or (ii) the patient is in a persistent vegetative state.</p><p>&quot;Treating physician&quot; means a physician who is providing or has previously provided medical treatment or evaluation to and has or previously had an ongoing treatment relationship with the person.</p><p>2015, cc. <a href="http://lis.virginia.gov/cgi-bin/legp604.exe?151+ful+CHAP0655" target="_blank" rel="noreferrer">655</a>, <a href="http://lis.virginia.gov/cgi-bin/legp604.exe?151+ful+CHAP0656" target="_blank" rel="noreferrer">656</a>.</p>',6),r=[o];function s(c,l,d,p,h,u){return i(),t("div",null,r)}const g=e(n,[["render",s]]);export{f as __pageData,g as default};
